David Weinkauf
Director/Board Member chez GENERATION URANIUM INC.
Profil
David Weinkauf is the founder of Next Level Health Sciences, Inc. He is currently the Director at Diitalk Communications, Inc., Independent Director at Generation Uranium, Inc., Director at Children's Wish Foundation of Alberta & NWT, Independent Director at Samurai Capital Corp., and Chief Business Development Officer at Allied Corp.
(Canada).
Previously, he served as the President of The Weco Group Ltd.
from 2011 to 2020.
He obtained his undergraduate degree from the University of Calgary in 1993.
Postes actifs de David Weinkauf
| Sociétés | Poste | Début |
|---|---|---|
| GENERATION URANIUM INC. | Director/Board Member | 11/04/2019 |
| ALLIED CORP. | Corporate Officer/Principal | - |
| SAMURAI CAPITAL CORP. | Director/Board Member | 17/12/2020 |
| Children's Wish Foundation of Alberta & NWT | Director/Board Member | - |
Next Level Health Sciences, Inc.
 Next Level Health Sciences, Inc. Information Technology ServicesTechnology Services The Canadian company creates novel formulations that promote a healthier relationship between consumers and adult use recreational substances. The private company also develops licensable technologies that improve the delivery of biopsychoactives™ and reduce the reliance and dependency on addictive substances by preventing much of the damage these substances cause in the body. The company's first product, Hangovr-18o™, prevents hangovers using plant-based ingredients to support enzyme production in the liver, naturally sourced humic-fulvic acid to hydrate and detoxify, and S-acetyl glutathione to prevent oxidative cellular damage. The integration of their expertise in biopsychoactives™ delivery technologies, their understanding of functional medicine, and their science-backed, evidence-based approach to novel fortified food and nutraceutical formulations uniquely positions them within the adult recreational intoxicants market. Next Level Health Sciences, Inc. is a Vancouver-based company founded by David Weinkauf, who has been the CEO since incorporation. | Founder | - |
Diitalk Communications, Inc.
 Diitalk Communications, Inc. Packaged SoftwareTechnology Services Diitalk Communications, Inc. engages in the development of rewards-based communication platform. Its platform offers local, long distance, and international free calls via data or wi-fi. The company is headquartered in Saskatoon, Canada. | Director/Board Member | - |
Anciens postes connus de David Weinkauf
| Sociétés | Poste | Fin |
|---|---|---|
| The Weco Group Ltd. | President | 01/03/2020 |
Formation de David Weinkauf
| University of Calgary | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ALLIED CORP. | Health Technology |
| GENERATION URANIUM INC. | Finance |
| SAMURAI CAPITAL CORP. | Finance |
| Entreprise privées | 4 |
|---|---|
Diitalk Communications, Inc.
Diitalk Communications, Inc. Packaged SoftwareTechnology Services Diitalk Communications, Inc. engages in the development of rewards-based communication platform. Its platform offers local, long distance, and international free calls via data or wi-fi. The company is headquartered in Saskatoon, Canada. | Technology Services |
| Children's Wish Foundation of Alberta & NWT | |
Next Level Health Sciences, Inc.
Next Level Health Sciences, Inc. Information Technology ServicesTechnology Services The Canadian company creates novel formulations that promote a healthier relationship between consumers and adult use recreational substances. The private company also develops licensable technologies that improve the delivery of biopsychoactives™ and reduce the reliance and dependency on addictive substances by preventing much of the damage these substances cause in the body. The company's first product, Hangovr-18o™, prevents hangovers using plant-based ingredients to support enzyme production in the liver, naturally sourced humic-fulvic acid to hydrate and detoxify, and S-acetyl glutathione to prevent oxidative cellular damage. The integration of their expertise in biopsychoactives™ delivery technologies, their understanding of functional medicine, and their science-backed, evidence-based approach to novel fortified food and nutraceutical formulations uniquely positions them within the adult recreational intoxicants market. Next Level Health Sciences, Inc. is a Vancouver-based company founded by David Weinkauf, who has been the CEO since incorporation. | Technology Services |
| The Weco Group Ltd. |
